LGND — Ligand Pharmaceuticals Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Ligand Pharmaceuticals Inc (LGND), worth $16.43M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Essex | $13.77M | 1.80% | -25.5% |
| Caxton Associates | $1.85M | 0.03% | -68.6% |
| Quadrature | $548.10K | 0.00% | NEW |
| Polymer | $266.78K | 0.04% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.